25 XP   0   0   10

Advanced Biomedical Technologies Inc
Buy, Hold or Sell?

Let's analyse Advanced Biomedical Technologies Inc together

PenkeI guess you are interested in Advanced Biomedical Technologies Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Advanced Biomedical Technologies Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Advanced Biomedical Technologies Inc

I send you an email if I find something interesting about Advanced Biomedical Technologies Inc.

Quick analysis of Advanced Biomedical Technologies Inc (30 sec.)










What can you expect buying and holding a share of Advanced Biomedical Technologies Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.11
Expected worth in 1 year
$-0.08
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$0.03
Return On Investment
4,641.7%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0006 - $0.0006
How sure are you?
50%

1. Valuation of Advanced Biomedical Technologies Inc (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-0.08 - $-0.03

Total Value Per Share

$-0.19 - $-0.15

2. Growth of Advanced Biomedical Technologies Inc (5 min.)




Is Advanced Biomedical Technologies Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$7.9m-$8.3m$447.7k5.6%

How much money is Advanced Biomedical Technologies Inc making?

Current yearPrevious yearGrowGrow %
Making money-$515.4k-$729.4k$213.9k41.5%
Net Profit Margin-190.2%-426.1%--

How much money comes from the company's main activities?

3. Financial Health of Advanced Biomedical Technologies Inc (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

What can you expect buying and holding a share of Advanced Biomedical Technologies Inc? (5 min.)

Welcome investor! Advanced Biomedical Technologies Inc's management wants to use your money to grow the business. In return you get a share of Advanced Biomedical Technologies Inc.

What can you expect buying and holding a share of Advanced Biomedical Technologies Inc?

First you should know what it really means to hold a share of Advanced Biomedical Technologies Inc. And how you can make/lose money.

Speculation

The Price per Share of Advanced Biomedical Technologies Inc is $0.0006. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Advanced Biomedical Technologies Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Advanced Biomedical Technologies Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.11. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Advanced Biomedical Technologies Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-1,216.8%-0.01-1,216.8%-0.01-1,730.9%-0.01-1,811.4%-0.01-1,854.4%
Usd Book Value Change Per Share0.011,160.4%0.011,160.4%-0.01-2,327.7%-0.01-1,375.9%-0.01-1,345.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.011,160.4%0.011,160.4%-0.01-2,327.7%-0.01-1,375.9%-0.01-1,345.1%
Usd Price Per Share0.05-0.05-0.07-0.05-0.07-
Price to Earnings Ratio-6.85--6.85--6.74--5.85--6.57-
Price-to-Total Gains Ratio7.18-7.18--5.01--3.08--11.70-
Price to Book Ratio-0.44--0.44--0.59--0.49--1.05-
Price-to-Total Gains Ratio7.18-7.18--5.01--3.08--11.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0006
Number of shares1666666
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.01-0.01
Usd Total Gains Per Share0.01-0.01
Gains per Quarter (1666666 shares)11,604.18-13,758.62
Gains per Year (1666666 shares)46,416.71-55,034.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1046417464070-55034-55044
2092833928240-110069-110078
301392501392410-165103-165112
401856671856580-220138-220146
502320842320750-275172-275180
602785002784920-330207-330214
703249173249090-385241-385248
803713343713260-440276-440282
904177504177430-495310-495316
1004641674641600-550345-550350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.017.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%3.014.00.017.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.017.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%3.014.00.017.6%

Fundamentals of Advanced Biomedical Technologies Inc

About Advanced Biomedical Technologies Inc

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

Fundamental data was last updated by Penke on 2024-05-26 20:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Advanced Biomedical Technologies Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Advanced Biomedical Technologies Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Advanced Biomedical Technologies Inc to the Medical Devices industry mean.
  • A Net Profit Margin of -190.2% means that $-1.90 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Advanced Biomedical Technologies Inc:

  • The MRQ is -190.2%. The company is making a huge loss. -2
  • The TTM is -190.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-190.2%TTM-190.2%0.0%
TTM-190.2%YOY-426.1%+235.9%
TTM-190.2%5Y-2,439.2%+2,249.0%
5Y-2,439.2%10Y-1,219.6%-1,219.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-190.2%-11.0%-179.2%
TTM-190.2%-16.5%-173.7%
YOY-426.1%-12.3%-413.8%
5Y-2,439.2%-19.6%-2,419.6%
10Y-1,219.6%-23.9%-1,195.7%
1.1.2. Return on Assets

Shows how efficient Advanced Biomedical Technologies Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Advanced Biomedical Technologies Inc to the Medical Devices industry mean.
  • -130.3% Return on Assets means that Advanced Biomedical Technologies Inc generated $-1.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Advanced Biomedical Technologies Inc:

  • The MRQ is -130.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -130.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-130.3%TTM-130.3%0.0%
TTM-130.3%YOY-162.6%+32.3%
TTM-130.3%5Y-349.3%+219.0%
5Y-349.3%10Y-462.8%+113.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-130.3%-3.3%-127.0%
TTM-130.3%-4.1%-126.2%
YOY-162.6%-3.6%-159.0%
5Y-349.3%-3.7%-345.6%
10Y-462.8%-4.1%-458.7%
1.1.3. Return on Equity

Shows how efficient Advanced Biomedical Technologies Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Advanced Biomedical Technologies Inc to the Medical Devices industry mean.
  • 0.0% Return on Equity means Advanced Biomedical Technologies Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Advanced Biomedical Technologies Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.7%+3.7%
TTM--4.2%+4.2%
YOY--4.6%+4.6%
5Y--5.6%+5.6%
10Y--5.8%+5.8%

1.2. Operating Efficiency of Advanced Biomedical Technologies Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Advanced Biomedical Technologies Inc is operating .

  • Measures how much profit Advanced Biomedical Technologies Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Advanced Biomedical Technologies Inc to the Medical Devices industry mean.
  • An Operating Margin of -66.4% means the company generated $-0.66  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Advanced Biomedical Technologies Inc:

  • The MRQ is -66.4%. The company is operating very inefficient. -2
  • The TTM is -66.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-66.4%TTM-66.4%0.0%
TTM-66.4%YOY-230.7%+164.3%
TTM-66.4%5Y-1,148.9%+1,082.5%
5Y-1,148.9%10Y-574.4%-574.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.4%-29.1%-37.3%
TTM-66.4%-13.8%-52.6%
YOY-230.7%-12.6%-218.1%
5Y-1,148.9%-18.5%-1,130.4%
10Y-574.4%-22.5%-551.9%
1.2.2. Operating Ratio

Measures how efficient Advanced Biomedical Technologies Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.66 means that the operating costs are $1.66 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Advanced Biomedical Technologies Inc:

  • The MRQ is 1.664. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.664. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.664TTM1.6640.000
TTM1.664YOY3.307-1.643
TTM1.6645Y12.289-10.625
5Y12.28910Y6.144+6.144
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6641.432+0.232
TTM1.6641.429+0.235
YOY3.3071.407+1.900
5Y12.2891.407+10.882
10Y6.1441.371+4.773

1.3. Liquidity of Advanced Biomedical Technologies Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Advanced Biomedical Technologies Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.04 means the company has $0.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Advanced Biomedical Technologies Inc:

  • The MRQ is 0.035. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.035. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.035TTM0.0350.000
TTM0.035YOY0.034+0.001
TTM0.0355Y0.027+0.008
5Y0.02710Y0.021+0.007
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0352.689-2.654
TTM0.0352.724-2.689
YOY0.0343.378-3.344
5Y0.0273.659-3.632
10Y0.0213.670-3.649
1.3.2. Quick Ratio

Measures if Advanced Biomedical Technologies Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Advanced Biomedical Technologies Inc to the Medical Devices industry mean.
  • A Quick Ratio of 0.00 means the company can pay off $0.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Advanced Biomedical Technologies Inc:

  • The MRQ is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.001. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.001TTM0.0010.000
TTM0.001YOY0.004-0.004
TTM0.0015Y0.010-0.009
5Y0.01010Y0.012-0.002
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0011.511-1.510
TTM0.0011.545-1.544
YOY0.0042.092-2.088
5Y0.0102.391-2.381
10Y0.0122.596-2.584

1.4. Solvency of Advanced Biomedical Technologies Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Advanced Biomedical Technologies Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Advanced Biomedical Technologies Inc to Medical Devices industry mean.
  • A Debt to Asset Ratio of 21.06 means that Advanced Biomedical Technologies Inc assets are financed with 2,105.6% credit (debt) and the remaining percentage (100% - 2,105.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Advanced Biomedical Technologies Inc:

  • The MRQ is 21.056. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 21.056. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ21.056TTM21.0560.000
TTM21.056YOY19.687+1.370
TTM21.0565Y25.725-4.668
5Y25.72510Y29.436-3.711
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ21.0560.416+20.640
TTM21.0560.400+20.656
YOY19.6870.339+19.348
5Y25.7250.437+25.288
10Y29.4360.454+28.982
1.4.2. Debt to Equity Ratio

Measures if Advanced Biomedical Technologies Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Advanced Biomedical Technologies Inc to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Advanced Biomedical Technologies Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.591-0.591
TTM-0.599-0.599
YOY-0.495-0.495
5Y-0.637-0.637
10Y-0.684-0.684

2. Market Valuation of Advanced Biomedical Technologies Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Advanced Biomedical Technologies Inc generates.

  • Above 15 is considered overpriced but always compare Advanced Biomedical Technologies Inc to the Medical Devices industry mean.
  • A PE ratio of -6.85 means the investor is paying $-6.85 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Advanced Biomedical Technologies Inc:

  • The EOD is -0.082. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.848. Based on the earnings, the company is expensive. -2
  • The TTM is -6.848. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.082MRQ-6.848+6.766
MRQ-6.848TTM-6.8480.000
TTM-6.848YOY-6.740-0.108
TTM-6.8485Y-5.853-0.996
5Y-5.85310Y-6.574+0.722
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.082-1.094+1.012
MRQ-6.848-1.706-5.142
TTM-6.848-2.226-4.622
YOY-6.740-2.651-4.089
5Y-5.853-2.385-3.468
10Y-6.574-2.035-4.539
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Advanced Biomedical Technologies Inc:

  • The EOD is -0.058. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.806. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.806. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.058MRQ-4.806+4.748
MRQ-4.806TTM-4.8060.000
TTM-4.806YOY-5.480+0.674
TTM-4.8065Y1.363-6.169
5Y1.36310Y-3.392+4.755
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.058-2.491+2.433
MRQ-4.806-3.228-1.578
TTM-4.806-2.976-1.830
YOY-5.480-5.572+0.092
5Y1.363-5.579+6.942
10Y-3.392-5.579+2.187
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Advanced Biomedical Technologies Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -0.44 means the investor is paying $-0.44 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Advanced Biomedical Technologies Inc:

  • The EOD is -0.005. Based on the equity, the company is expensive. -2
  • The MRQ is -0.445. Based on the equity, the company is expensive. -2
  • The TTM is -0.445. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.005MRQ-0.445+0.439
MRQ-0.445TTM-0.4450.000
TTM-0.445YOY-0.586+0.142
TTM-0.4455Y-0.491+0.046
5Y-0.49110Y-1.053+0.562
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0052.048-2.053
MRQ-0.4452.303-2.748
TTM-0.4452.496-2.941
YOY-0.5862.872-3.458
5Y-0.4914.072-4.563
10Y-1.0534.486-5.539
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Advanced Biomedical Technologies Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0070.0070%-0.014+301%-0.008+219%-0.008+216%
Book Value Per Share---0.112-0.1120%-0.119+6%-0.102-9%-0.080-29%
Current Ratio--0.0350.0350%0.034+3%0.027+29%0.021+71%
Debt To Asset Ratio--21.05621.0560%19.687+7%25.725-18%29.436-28%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps---0.007-0.0070%-0.010+42%-0.011+49%-0.011+52%
Free Cash Flow Per Share---0.010-0.0100%-0.013+23%-0.008-27%-0.008-20%
Free Cash Flow To Equity Per Share--0.0000.0000%-0.002+464%0.000-90%0.000-81%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.034--------
Intrinsic Value_10Y_min---0.079--------
Intrinsic Value_1Y_max---0.005--------
Intrinsic Value_1Y_min---0.008--------
Intrinsic Value_3Y_max---0.013--------
Intrinsic Value_3Y_min---0.025--------
Intrinsic Value_5Y_max---0.020--------
Intrinsic Value_5Y_min---0.041--------
Market Cap42134.880-8279%3530283.6003530283.6000%4916683.100-28%3796137.340-7%4917735.070-28%
Net Profit Margin---1.902-1.9020%-4.261+124%-24.392+1182%-12.196+541%
Operating Margin---0.664-0.6640%-2.307+247%-11.489+1631%-5.744+765%
Operating Ratio--1.6641.6640%3.307-50%12.289-86%6.144-73%
Pb Ratio-0.005+99%-0.445-0.4450%-0.586+32%-0.491+10%-1.053+137%
Pe Ratio-0.082+99%-6.848-6.8480%-6.740-2%-5.853-15%-6.574-4%
Price Per Share0.001-8233%0.0500.0500%0.070-29%0.054-7%0.070-29%
Price To Free Cash Flow Ratio-0.058+99%-4.806-4.8060%-5.480+14%1.363-453%-3.392-29%
Price To Total Gains Ratio0.086-8233%7.1817.1810%-5.012+170%-3.079+143%-11.698+263%
Quick Ratio--0.0010.0010%0.004-86%0.010-94%0.012-95%
Return On Assets---1.303-1.3030%-1.626+25%-3.493+168%-4.628+255%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share--0.0070.0070%-0.014+301%-0.008+219%-0.008+216%
Usd Book Value---7936430.000-7936430.0000%-8384174.000+6%-7163930.600-10%-5631144.300-29%
Usd Book Value Change Per Share--0.0070.0070%-0.014+301%-0.008+219%-0.008+216%
Usd Book Value Per Share---0.112-0.1120%-0.119+6%-0.102-9%-0.080-29%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.007-0.0070%-0.010+42%-0.011+49%-0.011+52%
Usd Free Cash Flow---734532.000-734532.0000%-897144.000+22%-534728.600-27%-581221.300-21%
Usd Free Cash Flow Per Share---0.010-0.0100%-0.013+23%-0.008-27%-0.008-20%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.002+464%0.000-90%0.000-81%
Usd Market Cap42134.880-8279%3530283.6003530283.6000%4916683.100-28%3796137.340-7%4917735.070-28%
Usd Price Per Share0.001-8233%0.0500.0500%0.070-29%0.054-7%0.070-29%
Usd Profit---515485.000-515485.0000%-729441.000+42%-886888.000+72%-843173.000+64%
Usd Revenue--270991.000270991.0000%171192.000+58%115485.400+135%57742.700+369%
Usd Total Gains Per Share--0.0070.0070%-0.014+301%-0.008+219%-0.008+216%
 EOD+1 -7MRQTTM+0 -0YOY+24 -75Y+18 -1310Y+18 -13

3.2. Fundamental Score

Let's check the fundamental score of Advanced Biomedical Technologies Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.082
Price to Book Ratio (EOD)Between0-1-0.005
Net Profit Margin (MRQ)Greater than0-1.902
Operating Margin (MRQ)Greater than0-0.664
Quick Ratio (MRQ)Greater than10.001
Current Ratio (MRQ)Greater than10.035
Debt to Asset Ratio (MRQ)Less than121.056
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.303
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Advanced Biomedical Technologies Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.322
Ma 20Greater thanMa 500.001
Ma 50Greater thanMa 1000.007
Ma 100Greater thanMa 2000.019
OpenGreater thanClose0.001
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-10-31. All numbers in thousands.

Summary
Total Assets396
Total Liabilities8,332
Total Stockholder Equity-7,936
 As reported
Total Liabilities 8,332
Total Stockholder Equity+ -7,936
Total Assets = 396

Assets

Total Assets396
Total Current Assets292
Long-term Assets103
Total Current Assets
Cash And Cash Equivalents 5
Inventory 248
Other Current Assets 40
Total Current Assets  (as reported)292
Total Current Assets  (calculated)292
+/-0
Long-term Assets
Property Plant Equipment 103
Long-term Assets  (as reported)103
Long-term Assets  (calculated)103
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,332
Long-term Liabilities0
Total Stockholder Equity-7,936
Total Current Liabilities
Short-term Debt 6,811
Accounts payable 0
Other Current Liabilities 686
Total Current Liabilities  (as reported)8,332
Total Current Liabilities  (calculated)7,497
+/- 835
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock1
Retained Earnings -11,501
Accumulated Other Comprehensive Income 661
Other Stockholders Equity 2,903
Total Stockholder Equity (as reported)-7,936
Total Stockholder Equity (calculated)-7,936
+/-0
Other
Cash and Short Term Investments 5
Common Stock Shares Outstanding 70,606
Current Deferred Revenue835
Liabilities and Stockholders Equity 396
Net Debt 6,806
Net Working Capital -8,040
Short Long Term Debt Total 6,811



Balance Sheet

All numbers in thousands.

 Trend2022-10-312021-10-312020-10-312019-10-312018-10-312017-10-312016-10-312015-10-312014-10-312013-10-312012-10-312011-10-312010-10-312009-10-312008-10-312007-10-312006-10-31
> Total Assets 
1
9
168
101
101
214
214
197
218
166
101
85
142
219
469
449
396
3964494692191428510116621819721421410110116891
   > Total Current Assets 
1
9
87
31
51
101
71
69
93
59
27
25
40
119
331
302
292
2923023311194025275993697110151318791
       Cash And Cash Equivalents 
1
9
79
11
39
79
49
48
74
38
7
7
7
6
202
37
5
5372026777387448497939117991
       Net Receivables 
0
0
8
20
13
22
22
21
19
18
20
17
33
50
29
0
0
00295033172018192122221320800
       Other Current Assets 
0
0
8
20
13
0
22
21
19
18
0
17
33
50
29
76
40
40762950331701819212201320800
   > Long-term Assets 
0
0
81
70
49
113
143
128
124
107
74
61
103
99
138
146
103
10314613899103617410712412814311349708100
       Property Plant Equipment 
0
0
81
70
49
103
142
127
108
107
72
61
103
99
138
146
103
10314613899103617210710812714210349708100
       Other Assets 
0
0
0
0
0
0
2
1
17
0
1
0
0
0
0
0
0
000000101712000000
> Total Liabilities 
13
2
918
1,364
1,591
1,776
2,440
3,132
3,956
4,627
4,463
5,080
5,761
6,697
7,871
8,833
8,332
8,3328,8337,8716,6975,7615,0804,4634,6273,9563,1322,4401,7761,5911,364918213
   > Total Current Liabilities 
13
2
918
1,364
1,591
1,776
2,440
3,132
3,956
4,627
4,463
5,080
5,761
6,697
7,864
8,833
8,332
8,3328,8337,8646,6975,7615,0804,4634,6273,9563,1322,4401,7761,5911,364918213
       Short-term Debt 
0
0
0
0
0
0
0
0
3,448
4,090
3,084
3,767
4,326
4,917
28
6,889
6,811
6,8116,889284,9174,3263,7673,0844,0903,44800000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
3,448
0
3,084
3,767
4,326
4,917
4,706
0
0
004,7064,9174,3263,7673,08403,44800000000
       Accounts payable 
0
2
27
31
159
558
507
1
1
0
0
223
0
2
0
2
0
020202230011507558159312720
       Other Current Liabilities 
13
0
891
1,333
1,432
1,218
1,933
3,131
508
537
1,379
1,313
1,436
1,642
6,492
698
686
6866986,4921,6421,4361,3131,3795375083,1311,9331,2181,4321,333891013
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
5,055
7
0
0
0075,0550000000000000
> Total Stockholder Equity
-13
7
-750
-1,263
-1,490
-1,563
-2,226
-2,934
-3,739
-4,461
-4,362
-4,995
-5,619
-6,478
-7,402
-8,384
-7,936
-7,936-8,384-7,402-6,478-5,619-4,995-4,362-4,461-3,739-2,934-2,226-1,563-1,490-1,263-7507-13
   Common Stock
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
1
1
11111111111111000
   Retained Earnings -11,501-10,986-10,256-9,581-8,633-7,679-6,988-6,263-5,400-4,572-3,682-2,923-2,436-1,619-1,061-551-513
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
500
558
392
441
1,063
1,536
1,669
1,906
1,928
1,949
2,521
2,674
2,740
2,768
2,832
2,871
2,903
2,9032,8712,8322,7682,7402,6742,5211,9491,9281,9061,6691,5361,063441392558500



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.